Loading clinical trials...
Loading clinical trials...
International, Multi-center, Open Label, Follow-up Extension Study Assessing the Long-term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Conditions
Interventions
PXT3003
Locations
23
United States
Department of Neurology, Cedars-Sinai Medical Center
Los Angeles, California, United States
Department of Neurology, McKnight Brain Institute
Gainesville, Florida, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Brigham and Women's Hospital
Boston, Massachusetts, United States
University of Michigan Health System
Ann Arbor, Michigan, United States
Department of Neurology, University of Minnesota
Minneapolis, Minnesota, United States
Start Date
March 7, 2017
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2024
Last Updated
February 20, 2024
NCT01193088
NCT05902351
NCT00484510
Lead Sponsor
Pharnext S.C.A.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions